Ambea CEO Mark Jensen has signaled that the Swedish animal health company intends to pursue further acquisitions, despite a growing debt burden following its recent bid for competitor Humana.
Jensen stated that the company possesses the financial "muscles" to continue its expansion strategy, emphasizing a preference for larger and stronger targets.
The comments come as Ambea navigates the integration of its latest potential deal, with the CEO indicating that the current capital structure supports additional growth initiatives.
The market reaction to the Humana bid has been mixed for the acquirer.
Ambea shares have traded sideways in recent sessions, while Humana's stock has surged on the news of the takeover offer.
This divergence highlights the market's cautious stance on Ambea's leverage levels, even as it rewards the target with a significant premium.